AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Post-LOE

amiloride hydrochloride and hydrochlorothiazide

Teva

ANDAORALTABLET

Approved

May 1988

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (amiloride hydrochloride and hydrochlorothiazide) by Teva. Approved for those patients with hypertension, congestive heart failure, other kaliuretic diuretics are used alone and 3 more indications. First approved in 1988.

Drug data last refreshed 1w ago

Mechanism of Action

Pharmacologic Class:

Thiazide Diuretic

Indications (6)

those patients with hypertension congestive heart failure

Worked on AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.